All In Biotech

Drug Trial Radar · NCT07044336

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)

Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Aug 1, 2025

Primary completion

Oct 15, 2027

Study completion Jul 17, 2029

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jun 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to physician's choice of chemotherapy (doxorubicin or paclitaxel) in participants with B7-H4 selected advanced/metastatic EC that progressed following platinum based chemotherapy and anti-PD-1/anti-PD-L1 therapy.

Conditions

  • Endometrial Cancer
  • Malignant Solid Tumour

Interventions

  • Puxitatug SamrotecanDrug

    2.4 mg/kg on Day 1 Q3W Route of administration: IV infusion

  • DoxorubicinDrug

    60 mg/m2 on Day 1 Q3W Route of administration: IV

  • PaclitaxelDrug

    80 mg/m2 on Days 1, 8, and 15 in 28-day cycle Route of Administration: IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free Survival (PFS) for Arm A vs Arm BTime frame: Approximately 3 years
  2. Overall survival (OS) for Arm A vs Arm BTime frame: Approximately 3 years

Locations

320 sites in 28 countries. Site status is shown where the registry gives one.

  • Research Site

    Tucson, Arizona · Not yet recruiting

  • Research Site

    La Jolla, California · Recruiting

  • Research Site

    Los Angeles, California · Withdrawn

  • Research Site

    Orange, California · Recruiting

  • Research Site

    Washington D.C., District of Columbia · Not yet recruiting

  • Research Site

    Jupiter, Florida · Recruiting

  • Research Site

    Miami, Florida · Not yet recruiting

  • Research Site

    Miami, Florida · Recruiting

  • Research Site

    Miami Beach, Florida · Recruiting

  • Research Site

    New Port Richey, Florida · Recruiting

  • Research Site

    Orlando, Florida · Recruiting

  • Research Site

    Tampa, Florida · Not yet recruiting

  • Research Site

    West Palm Beach, Florida · Recruiting

  • Research Site

    Honolulu, Hawaii · Not yet recruiting

  • Research Site

    Chicago, Illinois · Recruiting

  • Research Site

    Peoria, Illinois · Recruiting

  • Research Site

    Urbana, Illinois · Recruiting

  • Research Site

    Fort Wayne, Indiana · Recruiting

  • Research Site

    Indianapolis, Indiana · Recruiting

  • Research Site

    Scarborough, Maine · Recruiting

  • Research Site

    Baltimore, Maryland · Not yet recruiting

  • Research Site

    Baltimore, Maryland · Recruiting

  • Research Site

    Silver Spring, Maryland · Recruiting

  • Research Site

    Ann Arbor, Michigan · Not yet recruiting

  • Research Site

    Ann Arbor, Michigan · Recruiting

  • Research Site

    Detroit, Michigan · Withdrawn

  • Research Site

    Minneapolis, Minnesota · Recruiting

  • Research Site

    Camden, New Jersey · Not yet recruiting

  • Research Site

    Paramus, New Jersey · Recruiting

  • Research Site

    Albuquerque, New Mexico · Recruiting

  • Research Site

    Brooklyn, New York · Not yet recruiting

  • Research Site

    Stony Brook, New York · Recruiting

  • Research Site

    The Bronx, New York · Recruiting

  • Research Site

    White Plains, New York · Recruiting

  • Research Site

    Greenville, North Carolina · Recruiting

  • Research Site

    Pinehurst, North Carolina · Recruiting

  • Research Site

    Cincinnati, Ohio · Recruiting

  • Research Site

    Cleveland, Ohio · Recruiting

  • Research Site

    Cleveland, Ohio · Recruiting

  • Research Site

    Columbus, Ohio · Recruiting

Showing 40 of 320 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.